Collectively, these findings indicate that the various key pathways that control SREBP-1 activation and SREBP-1-regulated lipogenesis significantly participate in tumor growth and progression and may be a promising target in multiple malignancies (Table 2, Figure 2). The gene discussed is SREBF1; the disease is neoplasm.